Project

Green and digital continuous-flow pharmaceutical manufacturing

Acronym
GreenDigiPharma
Code
41Y03423
Duration
01 January 2023 → 31 December 2026
Funding
European funding: framework programme, Regional and community funding: Special Research Fund
Research disciplines
  • Natural sciences
    • Sustainable chemistry not elsewhere classified
Keywords
digitalisation
Other information
 
Project description

The European pharmaceutical industry is facing a significant challenge in greening and digitalising its manufacturing processes. A shortage of trained engineers and scientists hampers progress in this area. In this context, the EU-funded GreenDigiPharma project will produce a cohort of 10 highly skilled and trained PhD graduates who will spearhead the green and digital transformation of pharmaceutical manufacturing in both academic and industrial settings. The project will focus on pressing issues in sustainable manufacturing and explore greener methods for producing pharmaceutical products, incorporating innovative technologies such as heterogeneous nanocatalysts and biocatalysis, novel purification techniques and digitalisation tools. The GreenDigiPharma programme will also provide the early stage researchers with scientific and transferable knowledge on intellectual property rights, entrepreneurship, data management and innovation.

 
 
 
Disclaimer
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Union nor the authority can be held responsible for them.